(199 days)
Not Found
No
The summary describes a mechanical device (pedicle screws) and a bone cement. There is no mention of software, algorithms, or any technology that would suggest the use of AI or ML. The performance studies are bench tests focused on mechanical properties.
Yes.
The device is intended to restore the integrity of the spinal column in patients with advanced stage tumors, which addresses a pathological condition and therefore qualifies it as a therapeutic device.
No
The device description clearly states its purpose is to "restore the integrity of the spinal column" using screws and bone cement, which are therapeutic and structural functions, not diagnostic ones.
No
The device description clearly details physical components made of materials like carbon fiber-reinforced polyetheretherketone (CFR-PEEK), titanium, tantalum, and polymethylmethacrylate (PMMA). It also describes mechanical testing, indicating a hardware-based device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description and Intended Use: The description clearly states that the CarboClear Fenestrated Pedicle Screws and High V+ Bone Cement are implanted into the patient's spine to restore structural integrity. This is an in vivo (within the living body) application, not an in vitro (in glass/outside the body) test.
- Lack of Diagnostic Purpose: The intended use is therapeutic and structural support, not to diagnose a disease or condition by analyzing a sample.
Therefore, this device falls under the category of an implantable medical device, not an in vitro diagnostic.
N/A
Intended Use / Indications for Use
High V+ Bone Cement: When used in conjunction with the CarboClear Fenestrated Pedicle Screws, High V+ Bone Cement is intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy is of insufficient duration to permit achievement of fusion. High V+ Bone Cement is limited to use at spinal levels where the structural integrity of the spine is not severely compromised.
CarboClear Fenestrated Pedicle Screws: When used in conjunction with High V+ Bone Cement, the CarboClear Fenestrated Pedicle Screws are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy is of insufficient duration to permit achievement of fusion. CarboClear Fenestrated Pedicle Screws augmented with High V+ Bone Cement are for use at spinal levels where the structural integrity of the spine is not severely compromised.
Product codes (comma separated list FDA assigned to the subject device)
PML, NKB
Device Description
The CarboClear Fenestrated Pedicle Screws are cannulated polyaxial pedicle screws in various dimensions, with lateral fenestrations near screws' distal tip, which allow controlled delivery of polymethylmethacrylate (PMMA) bone cement (High V+ Bone Cement) into the vertebral body. The CarboClear Fenestrated Screws are implanted with components of the CarboClear Pedicle Screw System.
The CarboClear Fenestrated Screws are made of carbon fiber-reinforced polyetheretherketone (CFR-PEEK). The threaded portion of the screws is encased within a thin titanium shell, and includes a small tantalum marker.
The CarboClear Fenestrated Screws are supplied sterile, and are intended for single use.
The High V+ Bone Cement is a self-curing, high viscosity, radiopaque PMMA based bone cement. It is provided sterile in two components: 20 grams of powder and 8.6 grams of liquid. The powder component consists of polymethylmethacrylate, with barium sulfate and hydroxyapatite as radiopacifier, and benzoyl peroxide as an initiator. The liquid component comprises methylmethacrylate monomer, with N.Ndimethyl-p-toluidine as a promoter, and hydroquinone as a stabilizer. The powder and liquid components are mixed into homogenous paste, to initiate the polymerization reaction.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
thoracic and lumbar spine
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Comparative bench testing was provided to support substantial equivalence of the subject devices and their predicate devices. Mechanical testing included axial pullout strength test according to ASTM F2193 and ASTM F543, insertion and removal torque tests, and static bending and torsion tests. In addition, compatibility and performance test was conducted for CarboClear fenestrated screws and High V+ Bone Cement, to verify proper operation of the components and to characterize cement flow and bolus formation.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K161114, K180498, K173487, K182377
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3027 Polymethylmethacrylate (PMMA) bone cement.
(a)
Identification. Polymethylmethacrylate (PMMA) bone cement is a device intended to be implanted that is made from methylmethacrylate, polymethylmethacrylate, esters of methacrylic acid, or copolymers containing polymethylmethacrylate and polystyrene. The device is intended for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone.(b)
Classification. Class II (special controls). The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Polymethylmethacrylate (PMMA) Bone Cement.”
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG ADMINISTRATION' in blue text.
September 19, 2019
CarboFix Orthopedics Ltd. Ms. Hila Wachsler-Avrahami Regulatory Affairs 11 Ha'hoshlim Street Herzeliya, 4672411 ISRAEL
Re: K190526
Trade/Device Name: High V+ Bone Cement , CarboClear® Fenestrated Pedicle Screws Regulation Number: 21 CFR 888.3027 Regulation Name: Polymethylmethacrylate (PMMA) bone cement Regulatory Class: Class II Product Code: PML, NKB Dated: August 6, 2019 Received: August 12, 2019
Dear Ms. Wachsler-Avrahami:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Ronald P. Jean, Ph.D. Director (Acting) DHT6B: Division of Spinal Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K190526
Device Name High V+ Bone Cement
Indications for Use (Describe)
When used in conjunction with the CarboClear Fenestrated Pedicle Screws, High V+ Bone Cement is intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy is of insufficient duration to permit achievement of fusion. High V+ Bone Cement is limited to use at spinal levels where the structural integrity of the spine is not severely compromised.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Indications for Use
510(k) Number (if known) K190526
Device Name
CarboClear® Fenestrated Pedicle Screws
Indications for Use (Describe)
When used in conjunction with High V+ Bone Cement, the CarboClear Fenestrated Pedicle Screws are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy is of insufficient duration to permit achievement of fusion. CarboClear Fenestrated Pedicle Screws augmented with High V+ Bone Cement are for use at spinal levels where the structural integrity of the spine is not severely compromised.
Type of Use (Select one or both, as applicable)
| ☒ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(K) Summary CarboFix Orthopedics Ltd. CarboClear® Fenestrated Pedicle Screws and High V+ Bone Cement
Applicant Name
CarboFix Orthopedics, Ltd. 11 Ha'hoshlim St., Herzeliya 4672411, Israel Tel: +972 9 9511511, Fax: +972 9 9548939
Contact Person
Hila Wachsler-Avrahami
Date Prepared
February 28, 2019
| Trade / Proprietary
Name | High V+ Bone Cement | CarboClear® Fenestrated
Pedicle Screws |
|-----------------------------|----------------------------------------------|--------------------------------------------|
| Common Name | Polymethylmethacrylate
(PMMA) Bone Cement | Pedicle Screw System |
| Device Classification | Class II | Class II |
| Product Code | PML | NKB |
| Regulation Description | Bone Cement, Posterior
Screw Augmentation | Thoracolumbosacral Pedicle
Screw System |
| Regulation Number | 21 CFR §888.3027 | 21 CFR §888.3070 |
| Panel | Orthopaedic | Orthopaedic |
Device Regulation and Classification
Predicate Devices
The subject High V+ Bone Cement is substantially equivalent to the primary predicate device - High V+ (Teknimed® SAS; K161114); and to the additional predicate device - High V+ Bone Cement (NuVasive, Incorporated; K180498).
5
The subject CarboClear Fenestrated Pedicle Screws are substantially equivalent to the predicate device - CarboClear® Pedicle Screws (CarboFix Orthopedics Ltd.; K173487, K182377); and to the additional predicate devices - NuVasive® Reline® Fenestrated Screws (NuVasive, Incorporated; K180498).
Indications for Use
High V+ Bone Cement:
When used in conjunction with the CarboClear Fenestrated Pedicle Screws, High V+ Bone Cement is intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy is of insufficient duration to permit achievement of fusion. High V+ Bone Cement is limited to use at spinal levels where the structural integrity of the spine is not severely compromised.
CarboClear Fenestrated Pedicle Screws:
When used in conjunction with High V+ Bone Cement, the CarboClear Fenestrated Pedicle Screws are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy is of insufficient duration to permit achievement of fusion. CarboClear Fenestrated Pedicle Screws augmented with High V+ Bone Cement are for use at spinal levels where the structural integrity of the spine is not severely compromised.
System Description
The CarboClear Fenestrated Pedicle Screws are cannulated polyaxial pedicle screws in various dimensions, with lateral fenestrations near screws' distal tip, which allow controlled delivery of polymethylmethacrylate (PMMA) bone cement (High V+ Bone Cement) into the vertebral body. The CarboClear Fenestrated Screws are implanted with components of the CarboClear Pedicle Screw System.
The CarboClear Fenestrated Screws are made of carbon fiber-reinforced polyetheretherketone (CFR-PEEK). The threaded portion of the screws is encased within a thin titanium shell, and includes a small tantalum marker.
The CarboClear Fenestrated Screws are supplied sterile, and are intended for single use.
6
The High V+ Bone Cement is a self-curing, high viscosity, radiopaque PMMA based bone cement. It is provided sterile in two components: 20 grams of powder and 8.6 grams of liquid. The powder component consists of polymethylmethacrylate, with barium sulfate and hydroxyapatite as radiopacifier, and benzoyl peroxide as an initiator. The liquid component comprises methylmethacrylate monomer, with N.Ndimethyl-p-toluidine as a promoter, and hydroquinone as a stabilizer. The powder and liquid components are mixed into homogenous paste, to initiate the polymerization reaction.
Summary Comparison of Technological Characteristics and Intended Use with Predicate Devices
The subject CarboClear Fenestrated Pedicle Screws are similar to the cleared CarboClear Pedicle Screws (K173487, K182377) in their material, design, dimensions, production processes and sterilization, and additionally include lateral fenestrations at their distal portion. Furthermore, the CarboClear Fenestrated Pedicle Screws are implanted with the components of the cleared CarboClear Pedicle Screw System. The CarboClear Fenestrated Pedicle Screws are intended for the treatment of the same population as the cleared CarboClear Pedicle Screws, however their fixation is further augmented with bone cement.
In addition, the intended use, design, dimensions and principles of operation of the CarboClear Fenestrated Pedicle Screws are substantially equivalent to those of the additional predicate devices.
The subject High V+ Bone Cement is identical in composition production processes including sterilization, and its manufacturer to the primary predicate device - the High V+ bone cement (Teknimed, K161114; and NuVasive, K180498). Its delivery method (via fenestrated screws) and indications for use (patients with advanced stage spinal tumors and short life expectancy) are also similar to those of the High V+ Bone Cement (NuVasive, K180498).
Additionally, the indications for use, cement composition and principles of operation of the subject High V+ Bone Cement are substantially equivalent to those of the additional predicate devices.
Performance Data
Comparative bench testing was provided to support substantial equivalence of the subject devices and their predicate devices. Mechanical testing included axial pullout strength test according to ASTM F2193 and ASTM F543, insertion and removal torque tests, and static bending and torsion tests. In addition, compatibility and
7
performance test was conducted for CarboClear fenestrated screws and High V+ Bone Cement, to verify proper operation of the components and to characterize cement flow and bolus formation.
Conclusion
Based on the information provided in this Premarket Notification, the subject CarboClear Fenestrated Pedicle Screws and High V+ Bone Cement are substantially equivalent to their legally marketed predicate devices.